Table 5. Correlation of CP and NCP with CMR parameters in patients with HCM.
Parameter | CP (W) | NCP (W/100 g) | |||
---|---|---|---|---|---|
R (95% CI) | P value | R (95% CI) | P value | ||
CO (L/min) | 0.944 (0.916 to 0.963) | <0.001 | 0.406 (0.222 to 0.563) | <0.001 | |
CO/BSA (L/m2/min) | 0.846 (0.777 to 0.895) | <0.001 | 0.412 (0.228 to 0.567) | <0.001 | |
LV mass (g) | 0.551 (0.391 to 0.679) | <0.001 | −0.395 (−0.554 to −0.208) | <0.001 | |
LV mass/BSA (g/m2) | 0.386 (0.198 to 0.547) | <0.001 | −0.509 (−0.646 to −0.341) | <0.001 | |
SV (mL) | 0.789 (0.698 to 0.855) | <0.001 | 0.184 (−0.019 to 0.372) | 0.06 | |
SV/BSA (mL/m2) | 0.648 (0.513 to 0.752) | <0.001 | 0.158 (−0.016,0.349) | 0.11 | |
EDV (mL) | 0.760 (0.658 to 0.834) | <0.001 | 0.238 (0.036 to 0.423) | 0.02 | |
EDV/BSA (mL/m2) | 0.617 (0.473 to 0.729) | <0.001 | 0.049 (−0.155 to 0.249) | 0.63 | |
ESV (mL) | 0.422 (0.239 to 0.576) | <0.001 | −0.139 (−0.333 to 0.065) | 0.17 | |
ESV/BSA (mL/m2) | 0.303 (0.106 to 0.476) | 0.002 | −0.184 (−0.373 to 0.019) | 0.06 | |
EF (%) | 0.124 (−0.080 to 0.319) | 0.22 | 0.334 (0.140 to 0.503) | 0.001 | |
LGE (%) | −0.563 (−0.664 to −0.427) | <0.001 | −0.479 (−0.632 to −0.291) | <0.001 | |
LVMWT (mm) | −0.045 (−0.245 to 0.159) | 0.65 | 0.004 (−0.198 to 0.207) | 0.96 |
CP, cardiac power; NCP, normalized cardiac power; CMR, cardiac magnetic resonance; HCM, hypertrophic cardiomyopathy; CI, confidence interval; CO, cardiac output; BSA, body surface area; LV, left ventricle; SV, stroke volume; EDV, end-diastole volume; ESV, end-systolic volume; EF, ejection fraction; LGE, late gadolinium enhanced; LVMWT, left ventricular maximal wall thickness.